$VISM
VISIUM TECHNOLOGIES, INC.

2022 Q1 Form 10-Q Financial Statement

#000165495422000688 Filed on January 20, 2022

View on sec.gov

Income Statement

Concept 2022 Q1 2021 Q4 2021 Q3
Revenue $0.00 $0.00 $0.00
YoY Change -100.0%
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin $1.297M $1.265M $1.200M
YoY Change -52.62% 650.45% 521.14%
% of Gross Profit
Research & Development $78.29K $196.3K $110.4K
YoY Change 110.4% 16.22%
% of Gross Profit
Depreciation & Amortization
YoY Change
% of Gross Profit
Operating Expenses $1.375M $1.351M $1.310M
YoY Change -50.43% 652.35% 354.7%
Operating Profit -$1.375M -$1.351M -$1.310M
YoY Change -49.98% 652.35%
Interest Expense -$129.3K -$445.3K -$505.4K
YoY Change -174.22% -38.4% -618.75%
% of Operating Profit
Other Income/Expense, Net -$129.3K $60.04K -$505.4K
YoY Change -163.66% -106.08%
Pretax Income -$1.504M -$3.106M -$1.816M
YoY Change -40.91% 165.99% 425.3%
Income Tax $0.00
% Of Pretax Income
Net Earnings -$1.504M -$1.290M -$1.816M
YoY Change -40.91% 10.5% 425.3%
Net Earnings / Revenue
Basic Earnings Per Share
Diluted Earnings Per Share -$405.10 -$880.20 -$534.90
COMMON SHARES
Basic Shares Outstanding 3.620B shares
Diluted Shares Outstanding 432.5K shares 2.262M shares

Balance Sheet

Concept 2022 Q1 2021 Q4 2021 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $352.6K $361.6K $999.8K
YoY Change 27.7% 616.1% 51434.54%
Cash & Equivalents $352.6K $361.6K $999.8K
Short-Term Investments
Other Short-Term Assets $2.920K $20.42K $37.92K
YoY Change
Inventory
Prepaid Expenses $2.917K $20.42K
Receivables
Other Receivables
Total Short-Term Assets $355.5K $382.0K $1.038M
YoY Change 28.76% 656.54% 53389.18%
LONG-TERM ASSETS
Property, Plant & Equipment
YoY Change
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets $0.00 $0.00 $0.00
YoY Change
TOTAL ASSETS
Total Short-Term Assets $355.5K $382.0K $1.038M
Total Long-Term Assets $0.00 $0.00 $0.00
Total Assets $355.5K $382.0K $1.038M
YoY Change 28.76% 656.54% 53389.18%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $460.9K $516.2K $443.0K
YoY Change 20.03% 1.1%
Accrued Expenses $1.066M $1.051M $1.109M
YoY Change -19.52% -30.06% -22.88%
Deferred Revenue
YoY Change
Short-Term Debt $1.283M $670.4K $892.0K
YoY Change -18.01% -50.07% -21.44%
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $3.015M $2.366M $2.647M
YoY Change -31.34% -43.96% -22.65%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $0.00
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities $0.00 $0.00 $0.00
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities $3.015M $2.366M $2.647M
Total Long-Term Liabilities $0.00 $0.00 $0.00
Total Liabilities $3.015M $2.366M $2.647M
YoY Change -31.34% -43.96% -22.65%
SHAREHOLDERS EQUITY
Retained Earnings -$55.98M -$54.47M
YoY Change
Common Stock $380.5K $362.0K
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity -$2.659M -$1.984M -$1.610M
YoY Change
Total Liabilities & Shareholders Equity $355.5K $382.0K $1.038M
YoY Change 28.76% 656.54% 53389.18%

Cashflow Statement

Concept 2022 Q1 2021 Q4 2021 Q3
OPERATING ACTIVITIES
Net Income -$1.504M -$1.290M -$1.816M
YoY Change -40.91% 10.5% 425.3%
Depreciation, Depletion And Amortization
YoY Change
Cash From Operating Activities -$819.0K -$413.2K -$510.4K
YoY Change 93.06% 164.71% 2136.63%
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 810.0K -225.0K 1.385M
YoY Change 24.65% -209.94% -25281.82%
NET CHANGE
Cash From Operating Activities -819.0K -413.2K -510.4K
Cash From Investing Activities
Cash From Financing Activities 810.0K -225.0K 1.385M
Net Change In Cash -8.960K -638.2K 874.6K
YoY Change -103.97% -1414.27% -3188.28%
FREE CASH FLOW
Cash From Operating Activities -$819.0K -$413.2K -$510.4K
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2021Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2021Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
10000000000 shares
CY2021Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
3681071235 shares
CY2021Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
3620071235 shares
CY2021Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
3098271081 shares
CY2021Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
2946271099 shares
CY2021Q4 us-gaap Common Stock Value
CommonStockValue
362008 USD
CY2021Q2 us-gaap Common Stock Value
CommonStockValue
294627 USD
CY2021Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
52109948 USD
CY2021Q2 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
48217903 USD
CY2021Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-54471321 USD
CY2021Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-51365037 USD
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
-1984045 USD
CY2021Q2 us-gaap Stockholders Equity
StockholdersEquity
-2837187 USD
CY2021Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
381977 USD
CY2021Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
180584 USD
CY2021Q4 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
0 USD
CY2020Q4 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
0 USD
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
0 USD
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
0 USD
CY2021Q4 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
1264592 USD
CY2020Q4 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
168511 USD
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
2464629 USD
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
361707 USD
CY2021Q4 us-gaap Other Expenses
OtherExpenses
85912 USD
CY2020Q4 us-gaap Other Expenses
OtherExpenses
10994 USD
us-gaap Other Expenses
OtherExpenses
196325 USD
us-gaap Other Expenses
OtherExpenses
105994 USD
CY2021Q4 us-gaap Operating Expenses
OperatingExpenses
1350504 USD
CY2020Q4 us-gaap Operating Expenses
OperatingExpenses
179505 USD
CY2020Q4 us-gaap Operating Income Loss
OperatingIncomeLoss
-179505 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
-2660954 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
-467701 USD
CY2021Q4 us-gaap Derivative Gain Loss On Derivative Net
DerivativeGainLossOnDerivativeNet
75253 USD
CY2020Q4 us-gaap Derivative Gain Loss On Derivative Net
DerivativeGainLossOnDerivativeNet
-673826 USD
us-gaap Derivative Gain Loss On Derivative Net
DerivativeGainLossOnDerivativeNet
56345 USD
us-gaap Derivative Gain Loss On Derivative Net
DerivativeGainLossOnDerivativeNet
-549494 USD
CY2021Q4 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
0 USD
CY2020Q4 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
-53963 USD
us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
0 USD
CY2021Q4 vism Warrant Exercise Expense
WarrantExerciseExpense
0 USD
CY2022Q1 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
3620071235 shares
CY2021Q4 us-gaap Cash
Cash
361560 USD
CY2021Q2 us-gaap Cash
Cash
125166 USD
CY2021Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
20417 USD
CY2021Q2 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
55418 USD
CY2021Q4 us-gaap Assets Current
AssetsCurrent
381977 USD
CY2021Q2 us-gaap Assets Current
AssetsCurrent
180584 USD
CY2021Q4 us-gaap Assets
Assets
381977 USD
CY2021Q2 us-gaap Assets
Assets
180584 USD
CY2021Q4 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
516153 USD
CY2021Q2 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
425804 USD
CY2021Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
682529 USD
CY2021Q2 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
672529 USD
CY2021Q2 us-gaap Interest Payable Current
InterestPayableCurrent
366149 USD
CY2021Q4 vism Convertible Notes Payable To Asc Recap Llc
ConvertibleNotesPayableToAscRecapLlc
147965 USD
CY2021Q2 vism Convertible Notes Payable To Asc Recap Llc
ConvertibleNotesPayableToAscRecapLlc
147965 USD
CY2021Q4 us-gaap Debt Instrument Unamortized Discount Current
DebtInstrumentUnamortizedDiscountCurrent
0 USD
CY2021Q2 us-gaap Debt Instrument Unamortized Discount Current
DebtInstrumentUnamortizedDiscountCurrent
396033 USD
CY2021Q4 us-gaap Convertible Notes Payable Current
ConvertibleNotesPayableCurrent
317431 USD
CY2021Q2 us-gaap Convertible Notes Payable Current
ConvertibleNotesPayableCurrent
809195 USD
CY2021Q4 us-gaap Derivative Liabilities Current
DerivativeLiabilitiesCurrent
128036 USD
CY2021Q2 us-gaap Derivative Liabilities Current
DerivativeLiabilitiesCurrent
184381 USD
CY2021Q4 us-gaap Debt Instrument Unamortized Discount Noncurrent
DebtInstrumentUnamortizedDiscountNoncurrent
0 USD
CY2021Q2 us-gaap Debt Instrument Unamortized Discount Noncurrent
DebtInstrumentUnamortizedDiscountNoncurrent
18252 USD
CY2021Q4 us-gaap Notes Payable Current
NotesPayableCurrent
205000 USD
CY2021Q2 us-gaap Notes Payable Current
NotesPayableCurrent
411748 USD
CY2021Q4 us-gaap Liabilities Current
LiabilitiesCurrent
2366022 USD
CY2021Q2 us-gaap Liabilities Current
LiabilitiesCurrent
3017771 USD
CY2020Q4 vism Warrant Exercise Expense
WarrantExerciseExpense
211411 USD
vism Warrant Exercise Expense
WarrantExerciseExpense
0 USD
vism Warrant Exercise Expense
WarrantExerciseExpense
211411 USD
CY2021Q4 us-gaap Interest Expense Other
InterestExpenseOther
15211 USD
CY2020Q4 us-gaap Interest Expense Other
InterestExpenseOther
49096 USD
us-gaap Interest Expense Other
InterestExpenseOther
501675 USD
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-1045773 USD
us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
410922 USD
CY2021Q4 us-gaap Net Income Loss
NetIncomeLoss
-1290462 USD
us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
20128 USD
CY2020Q4 us-gaap Net Income Loss
NetIncomeLoss
-1167801 USD
us-gaap Net Income Loss
NetIncomeLoss
-3106284 USD
us-gaap Net Income Loss
NetIncomeLoss
-1513474 USD
CY2021Q4 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.000
vism Warrant Exercise Expense
WarrantExerciseExpense
211411 USD
CY2020Q4 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.001
us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.001
us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.001
CY2021Q4 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
3516595175 shares
CY2020Q4 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
2142394543 shares
us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
3273092114 shares
us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
1929418649 shares
CY2021Q3 us-gaap Stockholders Equity
StockholdersEquity
-1609690 USD
CY2021Q4 vism Shares Issued For Consulting Services Amount
SharesIssuedForConsultingServicesAmount
402583 USD
CY2021Q4 vism Shares Issued As Compensation Amount
SharesIssuedAsCompensationAmount
473000 USD
CY2021Q4 vism Amortization Of Deferred Compensation
AmortizationOfDeferredCompensation
40524 USD
CY2021Q4 us-gaap Net Income Loss
NetIncomeLoss
-1290462 USD
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
-1984045 USD
CY2021Q2 us-gaap Stockholders Equity
StockholdersEquity
-2837187 USD
vism Shares Issued For Consulting Services Amount
SharesIssuedForConsultingServicesAmount
729331 USD
us-gaap Stock Issued During Period Value Share Based Compensation Gross
StockIssuedDuringPeriodValueShareBasedCompensationGross
818000 USD
vism Shares Issued For Conversion Of Notes Payable And Accrued Interest Amount
SharesIssuedForConversionOfNotesPayableAndAccruedInterestAmount
831047 USD
vism Shares Issued Pursuant To Sale Of Common Stock Amount
SharesIssuedPursuantToSaleOfCommonStockAmount
1500000 USD
vism Shares Issued For Exercise Of Warrants Amount
SharesIssuedForExerciseOfWarrantsAmount
0 USD
vism Amortization Of Deferred Compensation
AmortizationOfDeferredCompensation
81048 USD
us-gaap Net Income Loss
NetIncomeLoss
-3106284 USD
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
-1984045 USD
CY2020Q3 us-gaap Stockholders Equity
StockholdersEquity
-3420814 USD
vism Amortization Of Deferred Compensation
AmortizationOfDeferredCompensation
81048 USD
vism Warrant Exercise Expense
WarrantExerciseExpense
0 USD
us-gaap Extinguishment Of Debt Gain Loss Net Of Tax
ExtinguishmentOfDebtGainLossNetOfTax
0 USD
CY2020Q4 vism Shares Issued For Consulting Services Amount
SharesIssuedForConsultingServicesAmount
12000 USD
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
90353 USD
CY2020Q4 us-gaap Stock Issued During Period Value Conversion Of Units
StockIssuedDuringPeriodValueConversionOfUnits
133029 USD
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
87698 USD
CY2020Q4 vism Shares Issued For Conversion Of Notes Payable Amount
SharesIssuedForConversionOfNotesPayableAmount
60718 USD
CY2020Q4 vism Shares Issued For Exercise Of Warrants Amount
SharesIssuedForExerciseOfWarrantsAmount
211411 USD
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
-4171461 USD
CY2020Q2 us-gaap Stockholders Equity
StockholdersEquity
-3380760 USD
us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
35000 USD
vism Amortization Of Deferred Compensation
AmortizationOfDeferredCompensation
0 USD
us-gaap Increase Decrease In Interest Payable Net
IncreaseDecreaseInInterestPayableNet
64368 USD
vism Shares Issued For Consulting Services Amount
SharesIssuedForConsultingServicesAmount
39000 USD
us-gaap Increase Decrease In Interest Payable Net
IncreaseDecreaseInInterestPayableNet
36466 USD
us-gaap Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
10000 USD
us-gaap Stock Issued During Period Value Share Based Compensation Gross
StockIssuedDuringPeriodValueShareBasedCompensationGross
45000 USD
us-gaap Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
136500 USD
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-178913 USD
us-gaap Sale Of Stock Consideration Received On Transaction
SaleOfStockConsiderationReceivedOnTransaction
1500000 USD
us-gaap Operating Expenses
OperatingExpenses
2660954 USD
us-gaap Operating Expenses
OperatingExpenses
467701 USD
CY2021Q4 us-gaap Operating Income Loss
OperatingIncomeLoss
-1350504 USD
us-gaap Interest Expense Other
InterestExpenseOther
76004 USD
CY2021Q4 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
60042 USD
CY2020Q4 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-988296 USD
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-445330 USD
vism Gain Loss On Change In Fair Value Of Derivative Liability
GainLossOnChangeInFairValueOfDerivativeLiability
-56345 USD
vism Gain Loss On Change In Fair Value Of Derivative Liability
GainLossOnChangeInFairValueOfDerivativeLiability
549494 USD
us-gaap Stock Issued During Period Value Conversion Of Units
StockIssuedDuringPeriodValueConversionOfUnits
133029 USD
vism Shares Issued For Conversion Of Notes Payable Amount
SharesIssuedForConversionOfNotesPayableAmount
294336 USD
vism Shares Issued For Exercise Of Warrants Amount
SharesIssuedForExerciseOfWarrantsAmount
211411 USD
us-gaap Net Income Loss
NetIncomeLoss
-1513474 USD
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
-4171461 USD
us-gaap Net Income Loss
NetIncomeLoss
-3106284 USD
us-gaap Net Income Loss
NetIncomeLoss
-1513474 USD
us-gaap Share Based Compensation
ShareBasedCompensation
1547332 USD
us-gaap Share Based Compensation
ShareBasedCompensation
84000 USD
us-gaap Sale Of Stock Consideration Received On Transaction
SaleOfStockConsiderationReceivedOnTransaction
0 USD
us-gaap Repayments Of Convertible Debt
RepaymentsOfConvertibleDebt
115000 USD
us-gaap Repayments Of Convertible Debt
RepaymentsOfConvertibleDebt
18879 USD
us-gaap Proceeds From Notes Payable
ProceedsFromNotesPayable
0 USD
us-gaap Proceeds From Notes Payable
ProceedsFromNotesPayable
320377 USD
us-gaap Repayments Of Notes Payable
RepaymentsOfNotesPayable
225000 USD
us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
0 USD
us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
0 USD
us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
102340 USD
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
1160000 USD
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
199158 USD
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
236394 USD
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
20245 USD
CY2021Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
125166 USD
CY2020Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
30251 USD
CY2021Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
361560 USD
CY2020Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
50492 USD
us-gaap Interest Paid Net
InterestPaidNet
22011 USD
us-gaap Interest Paid Net
InterestPaidNet
15807 USD
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
0 USD
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
0 USD
us-gaap Proceeds From Issuance Or Sale Of Equity
ProceedsFromIssuanceOrSaleOfEquity
831047 USD
us-gaap Proceeds From Issuance Or Sale Of Equity
ProceedsFromIssuanceOrSaleOfEquity
93256 USD
us-gaap Net Income Loss
NetIncomeLoss
-3106284 USD
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
923606 USD
CY2021Q4 vism Working Capital Deficit
WorkingCapitalDeficit
-1984045 USD
us-gaap Fiscal Period
FiscalPeriod
<p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">The fiscal year ends on June 30. References to fiscal year 2022, for example, refer to the fiscal year ending June 30, 2022.</p>
us-gaap Use Of Estimates
UseOfEstimates
<p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">The preparation of consolidated financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reporting amounts of revenues and expenses during the reported period. Actual results will differ from those estimates. Included in these estimates are assumptions used in Cox, Ross &amp; Rubinstein Binomial Tree stock-based compensation valuation methods, such as expected volatility, risk-free interest rate, and expected dividend rate and in the valuation allowance of deferred tax assets and derivative liability.</p>
us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">The Company is subject to a concentration of credit risk from cash.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">The Company’s cash account is held at a financial institution and is insured by the Federal Deposit Insurance Corporation, or FDIC, up to $250,000.</p>
CY2021Q4 us-gaap Cash Fdic Insured Amount
CashFDICInsuredAmount
250000 USD
CY2021Q4 us-gaap Derivative Liabilities
DerivativeLiabilities
128036 USD
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
3273092114 shares
CY2020 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
1977488957 shares
us-gaap Incremental Common Shares Attributable To Conversion Of Debt Securities
IncrementalCommonSharesAttributableToConversionOfDebtSecurities
95911155 shares
CY2020 us-gaap Incremental Common Shares Attributable To Conversion Of Debt Securities
IncrementalCommonSharesAttributableToConversionOfDebtSecurities
142079692 shares
us-gaap Incremental Common Shares Attributable To Conversion Of Preferred Stock
IncrementalCommonSharesAttributableToConversionOfPreferredStock
13996767 shares
CY2020 us-gaap Incremental Common Shares Attributable To Conversion Of Preferred Stock
IncrementalCommonSharesAttributableToConversionOfPreferredStock
13996767 shares
vism Incremental Common Shares Attributable To Common Stock Option
IncrementalCommonSharesAttributableToCommonStockOption
8000000 shares
us-gaap Incremental Common Shares Attributable To Call Options And Warrants
IncrementalCommonSharesAttributableToCallOptionsAndWarrants
6814782 shares
CY2020 us-gaap Incremental Common Shares Attributable To Call Options And Warrants
IncrementalCommonSharesAttributableToCallOptionsAndWarrants
12165260 shares
us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
3397814818 shares
CY2020 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
2145730676 shares
vism Prepaid License Fee
PrepaidLicenseFee
70000 USD
us-gaap Derivative Gain Loss On Derivative Net
DerivativeGainLossOnDerivativeNet
56345 USD
us-gaap Derivative Gain Loss On Derivative Net
DerivativeGainLossOnDerivativeNet
-549494 USD
vism Schedule The Fair Value Of The Warrants And Convertible Debt
ScheduleTheFairValueOfTheWarrantsAndConvertibleDebt
<table cellpadding="0" style="border-spacing:0;text-align:left;font:10pt times new roman;margin-left:auto;margin-right:auto;width:85%"><tbody><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><strong>December 31, </strong></p><p style="font-size:10pt;font-family:times new roman;margin:0px"><strong>2021</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>June 30, </strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>2021</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Derivative liability - warrants</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">14,500</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">69,334</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Derivative liability - convertible debt</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"/><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">113,536</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">115,047</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Total derivative liabilities</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 3px double;width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="BORDER-BOTTOM: 3px double;width:9%;vertical-align:bottom;text-align:right;">128,036</td><td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 3px double;width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="BORDER-BOTTOM: 3px double;width:9%;vertical-align:bottom;text-align:right;">184,381</td><td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr></tbody></table>
CY2021Q4 vism Derivative Liability Warrants
DerivativeLiabilityWarrants
14500 USD
CY2021Q2 vism Derivative Liability Warrants
DerivativeLiabilityWarrants
69334 USD
CY2021Q4 vism Derivative Liability Convertible Debt
DerivativeLiabilityConvertibleDebt
113536 USD
CY2021Q2 vism Derivative Liability Convertible Debt
DerivativeLiabilityConvertibleDebt
115047 USD
CY2021Q4 us-gaap Derivative Liabilities
DerivativeLiabilities
128036 USD
CY2021Q2 us-gaap Derivative Liabilities
DerivativeLiabilities
184381 USD
CY2021Q4 vism Derivative Liabilities Fair Value Assumptions Market Price
DerivativeLiabilitiesFairValueAssumptionsMarketPrice
0.0098
CY2020Q4 vism Derivative Liabilities Fair Value Assumptions Market Price
DerivativeLiabilitiesFairValueAssumptionsMarketPrice
0.006
vism Derivative Liabilities Fair Value Assumptions Expected Dividend Rate
DerivativeLiabilitiesFairValueAssumptionsExpectedDividendRate
0 pure
vism Derivative Liabilities Fair Value Assumptions Expected Dividend Rate
DerivativeLiabilitiesFairValueAssumptionsExpectedDividendRate
0 pure
CY2021Q2 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value
FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
184381 USD
us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Period Increase Decrease
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPeriodIncreaseDecrease
-56345 USD
CY2021Q4 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value
FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
128036 USD
CY2021Q2 us-gaap Interest Payable Current
InterestPayableCurrent
366149 USD
us-gaap Interest Expense Debt
InterestExpenseDebt
80771 USD
us-gaap Interest Paid
InterestPaid
22011 USD
vism Conversion Of Accrued Interest Into Common Stock
ConversionOfAccruedInterestIntoCommonStock
-56001 USD
CY2021Q4 us-gaap Interest Payable Current
InterestPayableCurrent
368908 USD
CY2021Q4 us-gaap Convertible Long Term Notes Payable
ConvertibleLongTermNotesPayable
317431 USD
CY2021Q2 us-gaap Convertible Long Term Notes Payable
ConvertibleLongTermNotesPayable
1205228 USD
CY2021Q4 vism Discount On Convertible Notes Payable
DiscountOnConvertibleNotesPayable
0 USD
CY2021Q2 vism Discount On Convertible Notes Payable
DiscountOnConvertibleNotesPayable
-396033 USD
CY2021Q4 vism Convertible Notes Payable To Related Parties Current
ConvertibleNotesPayableToRelatedPartiesCurrent
317431 USD
CY2021Q2 vism Convertible Notes Payable To Related Parties Current
ConvertibleNotesPayableToRelatedPartiesCurrent
809195 USD
CY2021Q2 vism Convertible Notes Payable To Asc Recap
ConvertibleNotesPayableToAscRecap
147965 USD
CY2021Q4 vism Convertible Notes Payable To Asc Recap
ConvertibleNotesPayableToAscRecap
147965 USD
CY2021Q4 us-gaap Convertible Debt
ConvertibleDebt
465396 USD
CY2021Q2 us-gaap Convertible Debt
ConvertibleDebt
957160 USD
CY2013Q3 vism Principal Amount
PrincipalAmount
25000 USD
CY2014Q2 vism Principal Amount
PrincipalAmount
125000 USD
CY2014Q2 us-gaap Debt Instrument Maturity Date
DebtInstrumentMaturityDate
2014-03-31
CY2013Q3 us-gaap Debt Instrument Maturity Date
DebtInstrumentMaturityDate
2016-05-06
us-gaap Debt Conversion Converted Instrument Shares Issued1
DebtConversionConvertedInstrumentSharesIssued1
198046241 shares
vism Debt Conversion Converted Instrument Principal
DebtConversionConvertedInstrumentPrincipal
772798 USD
vism Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Expired In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExpiredInPeriodWeightedAverageExercisePrice
0.0074
CY2021Q4 vism Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisableNumber
6814782 shares
CY2021Q4 vism Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageExercisePrice
0.0113
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber
6814782 shares
CY2021Q4 vism Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisableWeightedAverageExercisePrice
0.0113
vism Amount Converted Interest
AmountConvertedInterest
56000 USD
vism Conversion Expense
ConversionExpense
2250 USD
us-gaap Debt Conversion Converted Instrument Amount1
DebtConversionConvertedInstrumentAmount1
831047 USD
CY2021Q4 us-gaap Debt Instrument Convertible Conversion Price1
DebtInstrumentConvertibleConversionPrice1
0.00417
CY2021Q4 vism Promissory Notes
PromissoryNotes
205000 USD
CY2021Q2 vism Promissory Notes
PromissoryNotes
430000 USD
CY2021Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
10000000000 shares
us-gaap Stock Issued During Period Shares Conversion Of Convertible Securities
StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities
198046241 shares
us-gaap Stock Issued During Period Value Conversion Of Convertible Securities
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
831047 USD
CY2021Q4 us-gaap Debt Instrument Convertible Conversion Price1
DebtInstrumentConvertibleConversionPrice1
0.00417
vism Shares Issued As Warrent Shares
SharesIssuedAsWarrentShares
6587229 shares
CY2021Q4 vism Preferred Stock Has A Stated Value
PreferredStockHasAStatedValue
0.0001
CY2021Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2021Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber
12165260 shares
CY2021Q2 vism Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageExercisePrice
0.011
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Granted
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted
3753418 shares
vism Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGrantsInPeriodWeightedAverageExercisePrice
0.0105
vism Warrants Exercised
WarrantsExercised
-6565229 shares
vism Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisesInPeriodWeightedAverageExercisePrice
0.0074
vism Warrants Forfeited
WarrantsForfeited
-2538667 shares
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber
6814782 shares
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
P1Y10M2D
CY2021Q4 us-gaap Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
0.113
CY2021Q4 vism Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisableNumber
6814782 shares
CY2021Q4 vism Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisableWeightedAverageExercisePrice
0.0113
vism Outstanding Exercise Price
OutstandingExercisePrice
0.015
vism Recognized Non Cash Compensation Expense
RecognizedNonCashCompensationExpense
81048 USD
vism Recognized Non Cash Compensation Expense
RecognizedNonCashCompensationExpense
0 USD
us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
P0Y9M29D
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested Number Of Shares
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares
4250000 shares
CY2021 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P4Y
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P4Y
vism Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Forfeiture Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsForfeitureRate
0.0000 pure
CY2021 vism Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Forfeiture Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsForfeitureRate
0.0000 pure
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0.0000 pure
CY2021 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0.0000 pure
CY2021Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
16000000 shares
CY2021Q2 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Weighted Average Grant Date Fair Value
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue
0.015
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
0
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
0
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
8000000 shares
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
0.015
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
8000000 shares
CY2021Q4 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Weighted Average Grant Date Fair Value
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue
0.015
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P4Y5M1D
CY2021Q4 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
62481 USD
CY2021Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
132000000 shares
CY2021Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
0.0115
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
56000000 shares
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
0.0071
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeited In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod
10833333 shares
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeitures Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue
0.0080
vism Restricted Stock Awards Vested
RestrictedStockAwardsVested
-116166667 shares
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue
0.0110
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
61000000 shares
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
0.0090
vism Unrecognized Compensation Expense
UnrecognizedCompensationExpense
513500 USD
CY2021Q4 us-gaap Due To Officers Or Stockholders Current
DueToOfficersOrStockholdersCurrent
0 USD

Files In Submission

Name View Source Status
0001654954-22-000688-index-headers.html Edgar Link pending
0001654954-22-000688-index.html Edgar Link pending
0001654954-22-000688.txt Edgar Link pending
0001654954-22-000688-xbrl.zip Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
vism-20211231.xsd Edgar Link pending
vism-20211231_cal.xml Edgar Link unprocessable
vism-20211231_def.xml Edgar Link unprocessable
vism-20211231_lab.xml Edgar Link unprocessable
vism-20211231_pre.xml Edgar Link unprocessable
vism_10q.htm Edgar Link pending
vism_10qimg1.jpg Edgar Link pending
vism_10q_htm.xml Edgar Link completed
vism_ex311.htm Edgar Link pending
vism_ex312.htm Edgar Link pending
vism_ex321.htm Edgar Link pending
vism_ex322.htm Edgar Link pending